26th November 2020
We spoke with Dr Sarah McClelland and senior postdoctoral researcher in her group, Dr Nadeem Shaikh, about the team’s most recent paper, published in Cancer Research, which set out to explore the mechanisms of chromosomal instability in high-grade serous ovarian carcinoma – the most common type of ovarian cancer. The study sheds light on how these mechanisms may be able to be targeted to overcome treatment resistance in this cancer type.
Read more19th November 2020
November is Pancreatic Cancer Awareness Month and today (19th November) is World Pancreatic Cancer Day. Join us in looking back at some of our pancreatic cancer research from the last year.
Read more9th November 2020
We spoke with Dr Faraz Mardakheh from Barts Cancer Institute’s Centre for Cancer Cell and Molecular Biology about his most recent research paper, published today in Developmental Cell. The study sheds lights on how invasive cancer cells increase their protein-making capacity in order to boost their growth and invasive capabilities, and identifies a key player involved in this process, which may represent a target for therapeutic interventions.
Read more9th November 2020
Researchers from Barts Cancer Institute, Queen Mary University of London, and the University of Edinburgh have discovered a key protein that supports the production of healthy blood cells throughout life by regulating the inflammatory response. This is the first study to identify a protein that directly keeps in check blood stem cells’ immune responses to protect them from excessive damage and premature ageing.
Read more26th October 2020
Congratulations to Ryan McWilliams who has been awarded the Laparoscopic Passport (LapPass) – a certificate of proficiency in surgical skills that is recognised nationwide. Ryan is the first intercalating MBBS student undertaking the MSc Laparoscopic Surgery and Surgical Skills programme at Barts Cancer Institute, Queen Mary University of London, to get a LapPass in the UK.
Read more20th October 2020
Research led by Barts Cancer Institute, Queen Mary University of London, has revealed novel insights into the mechanisms employed by melanoma cells to form tumours at secondary sites around the body. The findings from the study may help to identify new targets to inhibit melanoma spread and guide treatment decisions in the clinic.
Read more